A Nanaimo woman who claims an injectable beauty treatment left her permanently disfigured will have her case heard in B.C. Supreme Court in February.
Sharon Logan launched a lawsuit against Dermatech, Intradermal Distribution Inc. and Vivier Pharma Inc. in B.C. Supreme Court in 2009.
Last year, the Supreme Court approved certification of Logan’s case as a class proceeding.
Logan alleges that she was not warned about the true risks associated with the use of Dermalive, a product licensed for use in Canada between 2003 and 2007 that was meant to be a permanent filler for wrinkles and other facial imperfections.
In May 2006, Logan had the product injected into her face and about six months later, she reported developing lumps on her face.
Her doctor tried to fix the problem with painful steroid injections to no avail and she has small bumps and red scars running along her lip, cheek and nose.
Her lawyer, David Rosenberg, said about 60 patients who were injected with Dermalive have signed on to the class action so far.
He said the case will go to trial starting on Feb. 25 and the hearing is scheduled to last 10 days.
In the meantime, Rosenberg said the details on how to give appropriate notice to potential class members are still before the courts.
Rosenberg said Dermalive’s maker, France-based Dermatech, went bankrupt and the ongoing litigation is against Intradermal Distribution Inc. and Vivier Pharma Inc., Canadian companies Logan’s suit alleges imported and distributed the product as a joint enterprise.
John Vamplew, a Vancouver lawyer representing Intradermal and Vivier Pharma, had no comment for the media about the case.
